Clinical Trial

A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study will primarily evaluate safety of the KNP-1000 apheresis system for pregnant women and their fetuses diagnosed with preeclampsia with severe features between 23- and 32-weeks' gestation (very preterm).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-28.
Trial Details
NCT Number NCT06580405
Lead Sponsor Kaneka Medical America LLC
Conditions Pre-Eclampsia, Severe
Enrollment 13 participants
Start Date 2025-05-31
Primary Completion 2026-04-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-05